Is there a correlation between hs-CRP levels and functional outcome of Ischemic Stroke?

Pakistan Journal of Medical Sciences

Volumn 29, Issue 1, 2012, Pages 166-169

  Taheraghdam, Aliakbar ^a   Aminnejad, Siamak ^b   Pashapour, Ali ^a   Rikhtegar, Reza ^a   Ghabili, Kamyar ^b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Atherosclerosis; C reactive protein; Functional outcome; Inflammation; Ischemic stroke; Modified Rankin scale

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISABILITY SEVERITY; FEMALE; FUNCTIONAL DISEASE; FUNCTIONAL STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANKIN SCALE;

EID: 84872938027     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: 10.12669/pjms.291.2799     Document Type: Article

References (22)

1. Kistorp C, Raymond I, Pedersen F, Gustafsson F, Faber J, Hildebrandt P. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA. 2005;293(13):1609-1616.
2. Elias-Smale SE, Kardys I, Oudkerk M, Hofman A, Witteman JC. C-reactive protein is related to extent and progression of coronary and extra-coronary atherosclerosis; results from the Rotterdam study. Atherosclerosis. 2007;195:e195-e202.
3. Koenig W, Sund M, Frohlich M, Fischer HG, Lowel H, Doring A, et al. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992 Circulation. 1999;99(2):237-242.
4. Becker KJ. Inflammation and acute stroke. Curr Opin Neurol. 1998;11:45-49.
5. Rost NS, Wolf PA, Kase CS, Kelly-Hayes M, Silbershatz H, Massaro JM, et al. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke. 2001;32:2575-2579.
6. Arenillas JF, Alvarez-Sabín J, Molina CA, Chacón P, Montaner J, Rovira A, et al. C-reactive protein predicts further ischemic events in first-ever transient ischemic attack or stroke patients with intracranial large-artery occlusive disease. Stroke. 2003;34:2463-2468.
7. Idicula TT, Brogger J, Naess H, Waje-Andreassen U, Thomassen L. Admission C-reactive protein after acute ischemic stroke is associated with stroke severity and mortality: the 'Bergen stroke study'. BMC Neurol. 2009;9:18.
8. Canova CR, Courtin C, Reinhart WH. C-reactive protein (CRP) in cerebro-vascular events. Atherosclerosis. 1999;147:49-53.
9. Muir KW, Weir CJ, Alwan W, Squire IB, Lees KR. C-reactive protein and outcome after ischemic stroke. Stroke. 1999;30:981-985.
10. Elkind MS, Tai W, Coates K, Paik MC, Sacco RL. Highsensitivity C-reactive protein, lipoprotein-associated phospholipase A2, and outcome after ischemic stroke. Arch Intern Med. 2006;166:2073-2080.
11. Audebert HJ, Rott MM, Eck T, Haberl RL. Systemic inflammatory response depends on initial stroke severity but is attenuated by successful thrombolysis. Stroke. 2004;35:2128-2133.
12. Modrego PJ, Boned B, Berlanga JJ, Serrano M. Plasmatic B-type natriuretic peptide and C-reactive protein in hyperacute stroke as markers of CT-evidence of brain edema. Int J Med Sci. 2008;5:18-23.
13. Song IU, Kim JS, Kim YI, Lee KS, Jeong DS, Chung SW. Relationship between high-sensitivity C-reactive protein and clinical functional outcome after acute ischemic stroke in a Korean population. Cerebrovasc Dis. 2009;28(6):545-550.
14. Ryu SR, Choi IS, Bian RX, Kim JH, Han JY, Lee SG. The effect of C-reactive protein on functional outcome in ischemic stroke patients. Int J Neurosci. 2009;119:336-344.
15. Scirica BM, Morrow DA. Is C-reactive protein an innocent bystander or proatherogenic culprit? The verdict is still out. Circulation. 2006;113(17):2128-2134.
16. Marquardt L, Ruf A, Mansmann U, Winter R, Buggle F, Kallenberg K, et al. Inflammatory response after acute ischemic stroke. J Neurol Sci. 2005;236:65-71.
17. Campbell DJ, Woodward M, Chalmers JP, Colman SA, Jenkins AJ, Kemp BE, et al. Soluble vascular cell adhesion molecule 1 and N-terminal pro-B-type natriuretic peptide in predicting ischemic stroke in patients with cerebrovascular disease. Arch Neurol. 2006;63(1):60-65.
18. Rallidis LS, Vikelis M, Panagiotakos DB, Rizos I, Zolindaki MG, Kaliva K, et al. Inflammatory markers and in-hospital mortality in acute ischaemic stroke. Atherosclerosis. 2006;189:193-197.
19. Kocer A, Canbulat C, Gozke E, Ilhan A. C-reactive protein is an indicator for fatal outcomes in first-time stroke patients. Med Sci Monit. 2005;11(11):CR540-CR544.
20. Arévalo-Lorido JC, Carretero-Gómez J, Calvo-Romero JM, Romero-Requena JM, Pérez-Alonso JL, Gutiérrez-Montaño C, et al. C-reactive protein in the acute phase of ischemic stroke. Med Clin (Barc). 2005;125:766-769.
21. Hamidon BB, Sapiah S, Nawawi H, Raymond AA. The prognostic value of C-reactive protein (CRP) levels in patients with acute ischaemic stroke. Med J Malaysia. 2004;59:631-637.
22. Di Napoli M, Schwaninger M, Cappelli R, Ceccarelli E, Di Gianfilippo G, Donati C, et al. Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members. Stroke. 2005;36:1316-1329.